Literature DB >> 17210687

Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1.

Min Wang1, Haris G Vikis, Yian Wang, Dongmei Jia, Daolong Wang, Laura J Bierut, Joan E Bailey-Wilson, Christopher I Amos, Susan M Pinney, Gloria M Petersen, Mariza de Andrade, Ping Yang, Jonathan S Wiest, Pamela R Fain, Ann G Schwartz, Adi Gazdar, John Minna, Colette Gaba, Henry Rothschild, Diptasri Mandal, Elena Kupert, Daniela Seminara, Yan Liu, Avinash Viswanathan, Ramaswamy Govindan, Marshall W Anderson, Ming You.   

Abstract

In this study, we observed loss of heterozygosity (LOH) in human chromosomal fragment 6q25.1 in sporadic lung cancer patients. LOH was observed in 65% of the 26 lung tumors examined and was narrowed down to a 2.2-Mb region. Single-nucleotide polymorphism (SNP) analysis of genes located within this region identified a candidate gene, termed p34. This gene, also designated as ZC3H12D, C6orf95, FLJ46041, or dJ281H8.1, carries an A/G nonsynonymous SNP at codon 106, which alters the amino acid from lysine to arginine. Nearly 73% of heterozygous lung cancer tissues with LOH and the A/G SNP also exhibited loss of the A allele. In vitro clonogenic and in vivo nude mouse studies showed that overexpression of the A allele exerts tumor suppressor function compared with the G allele. p34 is located within a recently mapped human lung cancer susceptibility locus, and association of the p34 A/G SNP was tested among these families. No significant association between the less frequent G allele and lung cancer susceptibility was found. Our results suggest that p34 may be a novel tumor suppressor gene involved in sporadic lung cancer but it seems not to be the candidate familial lung cancer susceptibility gene linked to chromosomal region 6q23-25.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17210687      PMCID: PMC3461257          DOI: 10.1158/0008-5472.CAN-06-2723

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization.

Authors:  C Luk; M S Tsao; J Bayani; F Shepherd; J A Squire
Journal:  Cancer Genet Cytogenet       Date:  2001-03

2.  What are the odds that smoking will kill you?

Authors:  M E Mattson; E S Pollack; J W Cullen
Journal:  Am J Public Health       Date:  1987-04       Impact factor: 9.308

3.  Chromosomal imbalances of primary and metastatic lung adenocarcinomas.

Authors:  Almut Goeze; Karsten Schlüns; Guenter Wolf; Zsuzsanna Thäsler; Simone Petersen; Iver Petersen
Journal:  J Pathol       Date:  2002-01       Impact factor: 7.996

4.  Sporadic breast cancer in young women: prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2.

Authors:  Suzanne M Johnson; Jacqueline A Shaw; Rosemary A Walker
Journal:  Int J Cancer       Date:  2002-03-10       Impact factor: 7.396

5.  Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer.

Authors:  Maria Cristina Picchio; Eric Santos Martin; Rossano Cesari; George Adrian Calin; Sai Yendamuri; Tamotsu Kuroki; Francesca Pentimalli; Manuela Sarti; Kristine Yoder; Larry R Kaiser; Richard Fishel; Carlo Maria Croce
Journal:  Clin Cancer Res       Date:  2004-04-15       Impact factor: 12.531

6.  A major lung cancer susceptibility locus maps to chromosome 6q23-25.

Authors:  J E Bailey-Wilson; C I Amos; S M Pinney; G M Petersen; M de Andrade; J S Wiest; P Fain; A G Schwartz; M You; W Franklin; C Klein; A Gazdar; H Rothschild; D Mandal; T Coons; J Slusser; J Lee; C Gaba; E Kupert; A Perez; X Zhou; D Zeng; Q Liu; Q Zhang; D Seminara; J Minna; M W Anderson
Journal:  Am J Hum Genet       Date:  2004-07-21       Impact factor: 11.025

7.  Butyrate response factor 1 is regulated by parathyroid hormone and bone morphogenetic protein-2 in osteoblastic cells.

Authors:  Sjur Reppe; Ole K Olstad; Edith Rian; Vigdis T Gautvik; Kaare M Gautvik; Rune Jemtland
Journal:  Biochem Biophys Res Commun       Date:  2004-11-05       Impact factor: 3.575

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

Review 9.  The genetic basis of susceptibility to lung tumors in mice.

Authors:  A M Malkinson
Journal:  Toxicology       Date:  1989-03       Impact factor: 4.221

10.  Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction.

Authors:  Limei Zhou; Asim Azfer; Jianli Niu; Sarabeth Graham; Mahua Choudhury; Frances M Adamski; Craig Younce; Phillip F Binkley; Pappachan E Kolattukudy
Journal:  Circ Res       Date:  2006-03-30       Impact factor: 17.367

View more
  19 in total

1.  The putative tumor suppressor Zc3h12d modulates toll-like receptor signaling in macrophages.

Authors:  Shengping Huang; Dongfei Qi; Jian Liang; Ruidong Miao; Kentaro Minagawa; Tim Quinn; Toshimitsu Matsui; Daping Fan; Jianguo Liu; Mingui Fu
Journal:  Cell Signal       Date:  2011-10-20       Impact factor: 4.315

2.  Monocyte Chemotactic Protein-induced Protein 1 and 4 Form a Complex but Act Independently in Regulation of Interleukin-6 mRNA Degradation.

Authors:  Shengping Huang; Shufeng Liu; Jia J Fu; T Tony Wang; Xiaolan Yao; Anil Kumar; Gang Liu; Mingui Fu
Journal:  J Biol Chem       Date:  2015-07-01       Impact factor: 5.157

Review 3.  Lung cancer in never smokers.

Authors:  Ping Yang
Journal:  Semin Respir Crit Care Med       Date:  2011-04-15       Impact factor: 3.119

4.  Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer.

Authors:  Maria Notaridou; Lydia Quaye; Dimitra Dafou; Chris Jones; Honglin Song; Estrid Høgdall; Susanne K Kjaer; Lise Christensen; Claus Høgdall; Jan Blaakaer; Valerie McGuire; Anna H Wu; David J Van Den Berg; Malcolm C Pike; Aleksandra Gentry-Maharaj; Eva Wozniak; Tanya Sher; Ian J Jacobs; Jonathan Tyrer; Joellen M Schildkraut; Patricia G Moorman; Edwin S Iversen; Anna Jakubowska; Krzysztof Mędrek; Jan Lubiński; Roberta B Ness; Kirsten B Moysich; Galina Lurie; Lynne R Wilkens; Michael E Carney; Shan Wang-Gohrke; Jennifer A Doherty; Mary Anne Rossing; Matthias W Beckmann; Falk C Thiel; Arif B Ekici; Xiaoqing Chen; Jonathan Beesley; Jacek Gronwald; Peter A Fasching; Jenny Chang-Claude; Marc T Goodman; Georgia Chenevix-Trench; Andrew Berchuck; C Leigh Pearce; Alice S Whittemore; Usha Menon; Paul D P Pharoah; Simon A Gayther; Susan J Ramus
Journal:  Int J Cancer       Date:  2011-05-01       Impact factor: 7.396

Review 5.  Epigenetics in non-small cell lung cancer: from basics to therapeutics.

Authors:  Junaid Ansari; Rodney E Shackelford; Hazem El-Osta
Journal:  Transl Lung Cancer Res       Date:  2016-04

6.  Mining the epigenome for methylated genes in lung cancer.

Authors:  Mathewos Tessema; Steven A Belinsky
Journal:  Proc Am Thorac Soc       Date:  2008-12-01

7.  MCPIP1 ribonuclease exhibits broad-spectrum antiviral effects through viral RNA binding and degradation.

Authors:  Ren-Jye Lin; Hsu-Ling Chien; Shyr-Yi Lin; Bi-Lan Chang; Han-Pang Yu; Wei-Chun Tang; Yi-Ling Lin
Journal:  Nucleic Acids Res       Date:  2013-01-25       Impact factor: 16.971

8.  Genome-wide survey and expression profiling of CCCH-zinc finger family reveals a functional module in macrophage activation.

Authors:  Jian Liang; Wenjun Song; Gail Tromp; Pappachan E Kolattukudy; Mingui Fu
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

9.  Identification of SNP-containing regulatory motifs in the myelodysplastic syndromes model using SNP arrays and gene expression arrays.

Authors:  Jing Fan; Jennifer G Dy; Chung-Che Chang; Xiaobo Zhou
Journal:  Chin J Cancer       Date:  2013-01-18

10.  Genome-wide analysis of loss of heterozygosity in breast infiltrating ductal carcinoma distant normal tissue highlights arm specific enrichment and expansion across tumor stages.

Authors:  Xiaoyang Ruan; Hongfang Liu; Lisa Boardman; Jean-Pierre A Kocher
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.